These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 25104845)

  • 21. Circadian rhythms in the efficacy of intravenous alteplase in patients with acute ischemic stroke and middle cerebral artery occlusion.
    Vilas D; Gomis M; Blanco M; Cortés J; Millán M; Pérez de la Ossa N; Dorado L; López-Cancio E; Suñol A; Dávalos A
    Chronobiol Int; 2012 Dec; 29(10):1383-9. PubMed ID: 23130962
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment with tPA predicts better outcome even if MCA occlusion persists.
    Kablau M; Alonso A; Hennerici MG; Fatar M
    Int J Stroke; 2013 Oct; 8(7):496-502. PubMed ID: 22340025
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential pattern of tissue plasminogen activator-induced proximal middle cerebral artery recanalization among stroke subtypes.
    Molina CA; Montaner J; Arenillas JF; Ribo M; Rubiera M; Alvarez-Sabín J
    Stroke; 2004 Feb; 35(2):486-90. PubMed ID: 14707233
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical and vascular outcome in internal carotid artery versus middle cerebral artery occlusions after intravenous tissue plasminogen activator.
    Linfante I; Llinas RH; Selim M; Chaves C; Kumar S; Parker RA; Caplan LR; Schlaug G
    Stroke; 2002 Aug; 33(8):2066-71. PubMed ID: 12154264
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Large-Vessel Occlusion Stroke: Effect of Recanalization on Outcome Depends on the National Institutes of Health Stroke Scale Score.
    Skagen K; Skjelland M; Russell D; Jacobsen EA
    J Stroke Cerebrovasc Dis; 2015 Jul; 24(7):1532-9. PubMed ID: 25922156
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety and efficacy of intravenous tissue plasminogen activator stroke treatment in the 3- to 6-hour window using multimodal transcranial Doppler/MRI selection protocol.
    Ribo M; Molina CA; Rovira A; Quintana M; Delgado P; Montaner J; Grivé E; Arenillas JF; Alvarez-Sabín J
    Stroke; 2005 Mar; 36(3):602-6. PubMed ID: 15692107
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Temporal profile of recanalization after intravenous tissue plasminogen activator: selecting patients for rescue reperfusion techniques.
    Ribo M; Alvarez-Sabín J; Montaner J; Romero F; Delgado P; Rubiera M; Delgado-Mederos R; Molina CA
    Stroke; 2006 Apr; 37(4):1000-4. PubMed ID: 16514102
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Perfusion computed tomography-guided intravenous thrombolysis for acute ischemic stroke beyond 4.5 hours: a case-control study.
    García-Bermejo P; Calleja AI; Pérez-Fernández S; Cortijo E; del Monte JM; García-Porrero M; Fe Muñoz M; Fernández-Herranz R; Arenillas JF
    Cerebrovasc Dis; 2012; 34(1):31-7. PubMed ID: 22759450
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recanalization after intravenous thrombolysis: does a recanalization time window exist?
    Wunderlich MT; Goertler M; Postert T; Schmitt E; Seidel G; Gahn G; Samii C; Stolz E; ;
    Neurology; 2007 Apr; 68(17):1364-8. PubMed ID: 17452580
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Arterial reocclusion in stroke patients treated with intravenous tissue plasminogen activator.
    Alexandrov AV; Grotta JC
    Neurology; 2002 Sep; 59(6):862-7. PubMed ID: 12297567
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factors associated with early recanalization failure following intravenous rt-PA therapy for ischemic stroke.
    Koga M; Arihiro S; Miyashita F; Yamamoto H; Yamada N; Nagatsuka K; Minematsu K; Toyoda K
    Cerebrovasc Dis; 2013; 36(4):299-305. PubMed ID: 24135558
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of pretreatment ASPECTS scores with tPA-induced arterial recanalization in acute middle cerebral artery occlusion.
    Tsivgoulis G; Saqqur M; Sharma VK; Lao AY; Hoover SL; Alexandrov AV;
    J Neuroimaging; 2008 Jan; 18(1):56-61. PubMed ID: 18190497
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Timing of recanalization after intravenous thrombolysis and functional outcomes after acute ischemic stroke.
    Yeo LL; Paliwal P; Teoh HL; Seet RC; Chan BP; Liang S; Venketasubramanian N; Rathakrishnan R; Ahmad A; Ng KW; Loh PK; Ong JJ; Wakerley BR; Chong VF; Bathla G; Sharma VK
    JAMA Neurol; 2013 Mar; 70(3):353-8. PubMed ID: 23599933
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Does Diffusion Lesion Volume Above 70 mL Preclude Favorable Outcome Despite Post-Thrombolysis Recanalization?
    Tisserand M; Turc G; Charron S; Legrand L; Edjlali M; Seners P; Roca P; Lion S; Naggara O; Mas JL; Méder JF; Baron JC; Oppenheim C
    Stroke; 2016 Apr; 47(4):1005-11. PubMed ID: 26979862
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Timing of recanalization after tissue plasminogen activator therapy determined by transcranial doppler correlates with clinical recovery from ischemic stroke.
    Christou I; Alexandrov AV; Burgin WS; Wojner AW; Felberg RA; Malkoff M; Grotta JC
    Stroke; 2000 Aug; 31(8):1812-6. PubMed ID: 10926939
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Buying time for recanalization in acute stroke: arterial blood infusion beyond the occluding clot as a neuroprotective strategy.
    Ribó M; Molina C; Alvarez B; Dinia L; Alvarez-Sabin J; Matas M
    J Neuroimaging; 2009 Apr; 19(2):188-90. PubMed ID: 18800999
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sonothrombolysis with transcranial color-coded sonography and recombinant tissue-type plasminogen activator in acute middle cerebral artery main stem occlusion: results from a randomized study.
    Eggers J; König IR; Koch B; Händler G; Seidel G
    Stroke; 2008 May; 39(5):1470-5. PubMed ID: 18340100
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Extending the time window for endovascular procedures according to collateral pial circulation.
    Ribo M; Flores A; Rubiera M; Pagola J; Sargento-Freitas J; Rodriguez-Luna D; Coscojuela P; Maisterra O; Piñeiro S; Romero FJ; Alvarez-Sabin J; Molina CA
    Stroke; 2011 Dec; 42(12):3465-9. PubMed ID: 21960574
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tissue plasminogen activator thrombolytic therapy for acute ischemic stroke in 4 hospital groups in Japan.
    Kono S; Deguchi K; Morimoto N; Kurata T; Deguchi S; Yamashita T; Ikeda Y; Matsuura T; Narai H; Omori N; Manabe Y; Yunoki T; Takao Y; Kawata S; Kashihara K; Abe K
    J Stroke Cerebrovasc Dis; 2013 Apr; 22(3):190-6. PubMed ID: 21968092
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic significance of blood pressure variability after thrombolysis in acute stroke.
    Delgado-Mederos R; Ribo M; Rovira A; Rubiera M; Munuera J; Santamarina E; Delgado P; Maisterra O; Alvarez-Sabin J; Molina CA
    Neurology; 2008 Aug; 71(8):552-8. PubMed ID: 18550860
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.